Comparative Cardiovascular Efficacy of SGLT2 Inhibitors, DPP-4 Inhibitors, and GLP-1 Agonists-A Network Meta-analysis

被引：0
|
作者：
Roddick, Alistair J.
Zheng, Sean
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-427-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1566): : 26 - 28
  • [32] SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?
    Cervantes, Carlos Escobar
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (08): : 507 - 508
  • [33] GLP-1 receptor agonists and SGLT2 inhibitors: a couple at last?
    Nauck, Michael A.
    Meier, Juris J.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (12): : 963 - 964
  • [34] Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
    Xie, Yan
    Bowe, Benjamin
    Xian, Hong
    Loux, Travis
    McGill, Janet B.
    Al-Aly, Ziyad
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (09): : 644 - 656
  • [35] SGLT2 inhibitors and GLP-1 receptor agonists: a sound combination
    De Block, Christophe
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (05): : 349 - 352
  • [36] Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study
    Narasaki, Yoko
    Kovesdy, Csaba P.
    You, Amy S.
    Sumida, Keiichi
    Mallisetty, Yamini
    Surbhi, Satya
    Thomas, Fridtjof
    Amin, Alpesh N.
    Streja, Elani
    Kalantar-Zadeh, Kamyar
    Rhee, Connie M.
    LANCET REGIONAL HEALTH-AMERICAS, 2024, 36
  • [37] Effects of DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta-analyses-driven approach
    Bronden, Andreas
    Christensen, Mikkel Bring
    Glintborg, Dorte
    Snorgaard, Ole
    Kofoed-Enevoldsen, Allan
    Madsen, Gitte Krogh
    Toft, Katja
    Kristensen, Jette Kolding
    Hojlund, Kurt
    Hansen, Troels Krarup
    Sondergaard, Esben
    Hansen, Katrine Bagge
    DIABETIC MEDICINE, 2023, 40 (08)
  • [38] GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician?
    Scheen, Andre J.
    ANNALES D ENDOCRINOLOGIE, 2013, 74 (5-6) : 515 - 522
  • [39] The Efficacy and Safety of Combinations of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes: A Systematic Review and Meta-analysis
    Guo, Man
    Gu, Junling
    Li, Jingsong
    Xu, Yong
    DIABETES, 2019, 68
  • [40] Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology
    Gaggini, Melania
    Sabatino, Laura
    Suman, Adrian Florentin
    Chatzianagnostou, Kyriazoula
    Vassalle, Cristina
    CELLS, 2025, 14 (05)
12345